Projected Income Statement: Elopak ASA

Forecast Balance Sheet: Elopak ASA

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 241 391 333 369 366 404 379 330
Change - 62.24% -14.83% 10.81% -0.81% 10.53% -6.19% -12.93%
Announcement Date 2/23/22 2/21/23 2/15/24 2/11/25 2/10/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Elopak ASA

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 37.38 126 31.98 109.1 85.65 85.97 89.33 82
Change - 237.09% -74.62% 241.18% -21.49% 0.37% 3.92% -8.21%
Free Cash Flow (FCF) 1 35.82 -100.9 125.2 30.85 85.43 60.8 92.8 119
Change - -381.74% 224.08% -75.36% 176.93% -28.83% 52.63% 28.23%
Announcement Date 2/23/22 2/21/23 2/15/24 2/11/25 2/10/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Elopak ASA

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 12.86% 11.66% 15.09% 15.23% 15.32% 14.84% 15.61% 15.94%
EBIT Margin (%) 6.86% 5.42% 9.68% 9.44% 9.56% 8.94% 9.9% 10.52%
EBT Margin (%) 5.32% 4.53% 7.5% 7.67% 7.1% 7.62% 8.32% 9.08%
Net margin (%) 3.6% 1.06% 5.92% 5.27% 5.11% 5.75% 6.18% 6.74%
FCF margin (%) 3.81% -9.86% 11.06% 2.67% 7.09% 4.87% 6.97% 8.39%
FCF / Net Income (%) 105.95% -929.58% 186.71% 50.64% 138.77% 84.68% 112.81% 124.6%

Profitability

        
ROA 4.41% 1.25% 6.99% 6.42% - - - -
ROE 14.88% 4.11% 23.71% 18.79% 18.08% 19.52% 20.52% 20.74%

Financial Health

        
Leverage (Debt/EBITDA) 1.99x 3.28x 1.95x 2.1x 1.98x 2.18x 1.82x 1.46x
Debt / Free cash flow 6.72x -3.88x 2.66x 11.98x 4.28x 6.64x 4.09x 2.77x

Capital Intensity

        
CAPEX / Current Assets (%) 3.98% 12.31% 2.82% 9.43% 7.1% 6.88% 6.71% 5.78%
CAPEX / EBITDA (%) 30.91% 105.52% 18.72% 61.96% 46.39% 46.36% 42.97% 36.28%
CAPEX / FCF (%) 104.36% -124.87% 25.54% 353.67% 100.26% 141.39% 96.26% 68.91%

Items per share

        
Cash flow per share 1 0.2807 - 0.5839 0.5284 0.6362 0.5 0.7 0.7
Change - - - -9.5% 20.4% -21.41% 40% 0%
Dividend per Share 1 0.0746 0.0785 0.1286 0.13 0.132 0.1454 0.1649 0.1944
Change - 5.13% 63.87% 1.11% 1.54% 10.17% 13.38% 17.87%
Book Value Per Share 1 0.9994 0.9639 1.138 1.272 1.26 1.397 1.563 1.82
Change - -3.55% 18.02% 11.78% -0.9% 10.84% 11.93% 16.42%
EPS 1 0.13 0.04 0.25 0.23 0.23 0.2677 0.3133 0.3608
Change - -69.23% 525% -8% 0% 16.4% 17.02% 15.17%
Nbr of stocks (in thousands) 269,219 269,213 268,952 268,893 268,631 268,646 268,646 268,646
Announcement Date 2/23/22 2/21/23 2/15/24 2/11/25 2/10/26 - - -
1EUR
Estimates
2026 *2027 *
P/E 12.3x 10.5x
PBR 2.35x 2.1x
EV / Sales 1.03x 0.95x
Yield 4.43% 5.02%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
3.284EUR
Average target price
3.774EUR
Spread / Average Target
+14.92%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ELO Stock
  4. Financials Elopak ASA